Skip to search.
 TSX Up 0.20% TSX Ventures Down 0.34%

Neuralstem, Inc. (CUR)

-NYSE MKT
3.72 Down 0.04(1.06%) Mar 2, 4:00PM EST
Add to Portfolio
Prev Close:3.76
Open:3.80
Bid:3.22 x 500
Ask:3.71 x 1500
1y Target Est:8.00
Beta:2.2
Next Earnings Date:N/A
Day's Range:3.66 - 3.81
52wk Range:2.12 - 4.81
Volume:778,875
Avg Vol (3m):932,405
Market Cap:324.98M
P/E (ttm):N/A
EPS (ttm):-0.24
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CURDown 1.06%324.98M
GERN 0.00%474.78M
STEMDown 0.89%76.29M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):19,708.98
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.25
Quarterly EPS Est (Dec-14) :-0.05
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Neuralstem, Inc., a biopharmaceutical company, focuses on the development and commercialization of treatments for central nervous system disease based on human neural stem cells and the use of small molecule compounds. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback